Abstract:ABSTRACT Current diagnostics and clinical management strategies for combat wounds are based on decisions made by expert clinicians. However, even in the hands of experienced surgeons, wounds from combat injuries can exhibit failed healing and complications related to limitations in the rapid and comprehensive generation of diagnostic information. Previous studies have demonstrated the possible use of genomic sequencing approaches to detect microbial signatures involved in combat casualty care. While effective, whole metagenome sequencing is limited by the depth required to confidently detect all relevant signatures. To address this, we developed a targeted capture sequencing panel to detect microbial signatures relevant to wound healing. These targets include known microbial nosocomial pathogens, wound colonizers, and genes involved in virulence and antimicrobial resistance. A bioinformatics pipeline was built to identify genomic regions of interest and over 8,000 oligonucleotide probes were designed for capture. The panel was synthesized and validated using control reference genomes in human background and on wound-effluent samples from a cohort of combat-injured U.S. service members. Our panel was sensitive against wound-colonizing species, Acinetobacter baumannii and Pseudomonas aeruginosa , and was specific in detecting corresponding virulence and antimicrobial-resistance genes as well as other pathogenic species present in microflora mixtures. Random forest feature permutation confirmed the prevalence of Acinetobacter and Pseudomonas in critically colonized wounds and wounds that failed to heal, respectively. Our results demonstrate the capability of targeted sequencing tools and analysis platforms to profile and deliver information on pathogenic factors influencing wound progression, thereby guiding therapeutic intervention. IMPORTANCE Microbial contamination in combat wounds can lead to opportunistic infections and adverse outcomes. However, current microbiological detection has a limited ability to capture microbial functional genes. This work describes the application of targeted metagenomic sequencing to profile wound bioburden and capture relevant wound-associated signatures for clinical utility. Ultimately, the ability to detect such signatures will help guide clinical decisions regarding wound care and management and aid in the prediction of wound outcomes.

A cell-free DNA metagenomic sequencing assay that integrates the host injury response to infection

Clinical Evaluation of Cell-Free and Cellular Metagenomic Next-Generation Sequencing of Infected Body Fluids

Metagenomic assay for identification of microbial pathogens in tumor tissues

Real-time Utilization of Metagenomic Sequencing in the Diagnosis and Treatment Monitoring of an Invasive Adenovirus B55 Infection and Subsequent Herpes Simplex Virus Encephalitis in an Immunocompetent Young Adult.

Clinical evaluation of cell-free (cf) and cellular metagenomic next-generation sequencing of infected body fluids

Phenotypic Pattern-Based Assay For Dynamically Monitoring Host Cellular Responses To Salmonella Infections

Targeted metagenomic assessment reflects critical colonization in battlefield injuries

Clinical characteristics of the host DNA-removed metagenomic next-generation sequencing technology for detecting SARS-CoV-2, revealing host local immune signaling and assisting genomic epidemiology

Unified metagenomic method for rapid detection of microorganisms in clinical samples

Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids

Harnessing the host response for precision infectious disease diagnosis

Toward Accurate Diagnosis and Surveillance of Bacterial Infections Using Enhanced Strain-Level Metagenomic Next-Generation Sequencing of Infected Body Fluids.

Validation and Retrospective Clinical Evaluation of a Quantitative 16S rRNA Gene Metagenomic Sequencing Assay for Bacterial Pathogen Detection in Body Fluids

Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids

A streamlined clinical metagenomic sequencing protocol for rapid pathogen identification

Utility of Microbial Cell Free DNA Next-Generation Sequencing for Diagnosis and Management of Infectious Diseases

INVADEseq to identify cell-adherent or invasive bacteria and the associated host transcriptome at single-cell-level resolution

Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid

Nanomechanical detection to empower robust monitoring of sepsis and microbial adaptive immune system-mediated proinflammatory disease

Development of a clinical metagenomics workflow for the diagnosis of wound infections

An integrated method for targeted Oxford Nanopore sequencing and automated bioinformatics for the simultaneous detection of bacteria, fungi, and ARG